Other
Income taxes payable – long-term
Neurocrine Biosciences Income taxes payable – long-term increased by 12.5% to $241.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 45.4%, from $166.00M to $241.30M. Over 2 years (FY 2023 to FY 2025), Income taxes payable – long-term shows an upward trend with a 49.5% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryRisk
SignalContext dependent
VolatilityStable
First reportedQ4 2023
Last reportedQ1 2026May 5, 2026
How to read this metric
An increase may indicate deferred tax liabilities growing due to timing differences, while a decrease suggests the settlement of long-term tax obligations.
Detailed definition
This represents the portion of income tax liabilities that are expected to be settled beyond the next twelve months. It...
Peer comparison
Commonly found in most capital-intensive firms with complex global tax structures.
Metric ID:
other_accrued_income_taxes_noncurrentHistorical Data
10 periods
| Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $96.00M | $101.10M | $111.00M | $134.90M | $160.70M | $166.00M | $183.00M | $195.50M | $214.50M | $241.30M |
| QoQ Change | — | +5.3% | +9.8% | +21.5% | +19.1% | +3.3% | +10.2% | +6.8% | +9.7% | +12.5% |
| YoY Change | — | — | — | — | +67.4% | +64.2% | +64.9% | +44.9% | +33.5% | +45.4% |
Range$96.00M – $241.30M
CAGR+50.6%
Avg YoY Growth+53.4%
Median YoY Growth+54.8%
Current Streak9+ quarters growth
Income taxes payable – long-term at Other Companies
Frequently Asked Questions
- What is Neurocrine Biosciences's income taxes payable – long-term?
- Neurocrine Biosciences (NBIX) reported income taxes payable – long-term of $241.30M in Q1 2026.
- How has Neurocrine Biosciences's income taxes payable – long-term changed year-over-year?
- Neurocrine Biosciences's income taxes payable – long-term increased by 45.4% year-over-year, from $166.00M to $241.30M.
- What is the long-term trend for Neurocrine Biosciences's income taxes payable – long-term?
- Over 2 years (2023 to 2025), Neurocrine Biosciences's income taxes payable – long-term has grown at a 49.5% compound annual growth rate (CAGR), from $96.00M to $214.50M.
- What does income taxes payable – long-term mean?
- Long-term income tax obligations that are not due within the next year.